Curis Lifesciences Financials

NSE: CURIS

₹142.00

₹0.05 (0.04%)

As on 03-Sep-2026 09:45IST

Market cap

₹115 Cr

Revenue (TTM)

₹49 Cr

P/E Ratio

16.6

P/B Ratio

2.4

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	49.13	35.56	35.45	23.75	--	--
Total Income	49.65	35.87	36.42	23.76	--	--
Total Expenditure	39.58	27.11	32.14	20.14	--	--
EBITDA	9.55	8.44	3.31	3.60	--	--
Depreciation	0.67	0.68	0.73	0.75	--	--
EBIT	8.87	7.76	2.59	2.85	--	--
Interest	1.12	0.90	1.36	1.64	--	--
Other Income	0.51	0.31	0.97	0.02	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	8.27	7.17	2.19	1.23	--	--
Provision for Tax	2.16	2.31	0.31	0.73	--	--
Profit after Tax	6.11	4.87	1.88	0.49	--	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	16.23	5.87	1.01	-0.90	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	8.73	9.80	10.18	12.49	--	--
Current Liabilities	17.58	18.20	18.56	15.81	--	--
Total Liabilities	42.53	33.88	29.75	27.40	--	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	11.24	11.77	12.37	12.52	--	--
Current Assets	31.29	22.11	17.37	14.88	--	--
Total Assets	42.53	33.88	29.75	27.40	--	--
Total Debt*	15.62	17.09	16.19	17.62	--	--
Net Current Assets	13.72	3.91	-1.19	-0.93	--	--
Contingent Liabilities	0.21	0.21	0.21	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	-1.76	0.28	3.35	4.95	--	--
Cash Flow from Investing Activities	-0.02	-0.06	-0.56	-0.37	--	--
Cash from Financing Activities	1.67	0.05	-2.76	-4.58	--	--
Net Cash Inflow / Outflow	-0.11	0.27	0.04	-0.01	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	10.29	8.85	3.41	0.90	--	--
Cash EPS (₹)	11.42	10.08	4.73	2.27	--	--
Adjusted Book Value (₹)	27.34	10.68	1.83	-1.64	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-2.97	5.60	67.10	98.92	--	--
Free Cash Flow per Share (₹)	-5.99	-58.73	22.23	43.94	--	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	34.25	40.22	20.96	17.12	--	--
ROE (%)	55.25	141.51	3,669.86	--	--	--
ROA (%)	15.98	15.30	6.56	1.80	--	--
EBIT Margin (%)	18.06	21.83	7.29	11.99	--	--
Net Margin (%)	12.30	13.57	5.15	2.07	--	--
Cash Profit Margin (%)	13.80	15.60	7.34	5.25	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	38.18	0.30	49.29	--	--	--
EBIT Growth (%)	14.31	200.18	-9.14	--	--	--
Net Profit Growth (%)	25.44	159.53	280.85	--	--	--
EPS Growth (%)	16.26	159.53	280.83	--	--	--
Book Value Growth (%)	176.31	483.89	211.31	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.11	1.96	3.86	4.98	--	--
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	0.96	2.91	16.10	-19.50	--	--
Short term debt to equity ratio	0.44	1.21	5.06	-3.98	--	--
Current Ratio	1.78	1.21	0.94	0.94	--	--
Quick Ratio	0.73	0.72	0.66	0.60	--	--
Interest Coverage	8.41	8.95	2.61	1.75	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	15.31	28.39	26.93	26.30	--	--
Asset Turnover	1.29	1.12	1.24	0.87	--	--
Receivable days	65.45	100.82	81.29	95.98	--	--
Inventory Days	101.63	72.22	53.97	82.63	--	--
Payable days	121.29	274.17	228.97	359.28	--	--
Cash Conversion Cycle	45.79	-101.14	-93.71	-180.68	--	--